Assays for diagnosis of thrombophilic disease
AssigneeMount Sinai School of Medicine of the City University of New York
InventorJacob H. Rand
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for diagnosing and/or monitoring thrombophilic disease in a patient that can result from the antiphospholipid antibody syndrome (aPL syndrome). The methods of the invention are premised on the inhibition of binding of an anticoagulant protein, annexin, preferably annexin-V, to phospholipids by antiphospholipid (aPL) antibodies in a patient blood sample.
Claims34
A method of diagnosing and/or monitoring a thrombophilic disease in a patient comprising
- a. incubating a phospholipid substrate with a test blood specimen from the patient in the presence of a known amount of an annexin for a time sufficient to allow the annexin to bind to the phospholipid substrate,
- b. removing unbound test specimen and annexin from the phospholipid substrate,
- c. measuring the amount of annexin bound to the phospholipid substrate in the presence of the test specimen, and
- d. comparing the amount of annexin bound in the presence of the test specimen to the same known amount of annexin bound to a phospholipid substrate in the presence of a control blood specimen, wherein a lower amount of annexin bound to the phospholipid substrate in the presence of the test specimen compared with the control specimen indicates the presence of thrombophilic disease in the individual.
A method of diagnosing and/or monitoring a thrombophilic disease in a patient comprising
- a. incubating a phospholipid substrate with a test blood specimen from the patient in the presence of a known amount of an annexin for a time sufficient to allow the annexin to bind to the phospholipid substrate,
- b. removing unbound test specimen and annexin from the phospholipid substrate,
- c. measuring the amount of unbound annexin from step b, and
- d. comparing the amount of unbound annexin from step b to an amount of unbound annexin in a sample of annexin bound to a phospholipid substrate in the presence of a control blood specimen, wherein a higher amount of unbound annexin in the presence of the test specimen compared to the amount of unbound annexin in the presence of the control specimen indicates the presence of thrombophilic disease.
A method of diagnosing and/or monitoring thrombophilic disease in a patient comprising
- a. incubating in duplicate a phospholipid dependent coagulation test reagent with a sample of anticoagulated patient plasma,
- b. calcifying the plasma in one of the duplicate sample of step a in the presence of a standardized amount of annexin and calcifying the plasma in the other sample in the absence of annexin, and
- c. monitoring the time until clot formation occurs in each sample, wherein a reduced anticoagulant effect in the presence of annexin indicates thrombophilic disease in the patient.
A method of diagnosing and/or monitoring thrombophilic disease in a patient compising
- a. incubating in duplicate a phospholipid dependent coagulation test reagent with a sample of anticoagulated patient plasma or isolated patient IgG,
- b. removing unbound plasma or IgG from the coagulation test reagent,
- c. incubating the duplicate samples of step b with a sample of control plasma,
- d. calcifying the control plasma in one of the duplicate samples of step c in the presence of a standardized amount of annexin and calcifying the control plasma in the other sample in the absence of annexin, and
- e. monitoring the time until clot formation occurs in each sample, wherein a reduced anticoagulant effect in the presence of annexin indicates thrombophilic disease in the patient.
Dependencies are inferred from the claim text.